Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

PURPOSE: Little is known about outcomes in the use of third-line chemotherapy in cases of advanced gastric cancer (AGC). The primary aim of this retrospective study was to evaluate outcomes of docetaxel-based chemotherapy in patients with AGC that progressed after both oxaliplatin-based and irinotec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Min Jeong, Hwang, In Gyu, Jang, Joung-Soon, Choi, Jin Hwa, Park, Byeong-Bae, Chang, Myung Hee, Kim, Seung Tae, Park, Se Hoon, Kang, Myoung Hee, Kang, Jung Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546270/
https://www.ncbi.nlm.nih.gov/pubmed/23341787
http://dx.doi.org/10.4143/crt.2012.44.4.235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546270/
https://www.ncbi.nlm.nih.gov/pubmed/23341787
http://dx.doi.org/10.4143/crt.2012.44.4.235

Ejemplares similares